Cardiovascular Research Advance Access originally published online on June 25, 2008
Cardiovascular Research 2008 80(2):200-208; doi:10.1093/cvr/cvn177
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Heart-specific isoform of tropomyosin4 is essential for heartbeat in zebrafish embryos



1 Protein Science Laboratory of the Ministry of Education, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, People's Republic of China
2 Laboratory of Cell Proliferation and Differentiation of the Ministry of Education, College of Life Sciences, Peking University, Beijing 100871, People's Republic of China
* Corresponding author. Tel: +86 10 62772256; fax: +86 10 62794401. E-mail address: mengam{at}mail.tsinghua.edu.cn
Received 12 February 2008; revised 17 May 2008; accepted 19 June 2008
Time for primary review: 34 days
| Abstract |
|---|
|
|
|---|
Aims: Tropomyosin (Tpm) proteins, encoded by four Tpm genes (Tpm1–4), are associated with the stabilization of the F-actin filaments and play important roles in modulating muscle contraction. So far, little is known about Tpm4 function in embryonic heart development and its involvement in the cardiovascular diseases. In this study, we investigated functions of different isoforms of tpm4 in embryonic heartbeat in zebrafish.
Methods and results: The transgenic zebrafish line, T2EGEZ8, was generated by insertion of a Tol2 transposon gene trap vector, and homozygous mutants (T2EGEZ8m/m) of this line showed failure of embryonic heartbeat without other detectable phenotypes. Observation by transmission electron microscopy revealed that the ventricular myocytes of mutant fish contained fewer, disorganized myofibrillar filaments. The transposon genome in T2EGEZ8 fish was found by thermal asymmetric interlaced-polymerase chain reaction (TAIL-PCR) and reverse transcription-polymerase chain reaction to have inserted into the ninth intron of the tpm4 locus, which resulted in production of Tpm4-GFP fusion proteins and loss of normal transcripts tpm4-tv1 and tpm4-tv2. Whole-mount in situ hybridization indicated that tpm4-tv1, encoding a peptide of 284 residues, is specifically expressed in the heart of zebrafish embryos, while tpm4-tv2, encoding a peptide of 248 residues, is mainly present in the vasculature but absent in the heart. Knockdown of tpm4-tv1 and tpm4-tv2 within wild-type embryos led to the failure of heartbeat, which could be rescued by coinjection with tpm4-tv1 mRNA but not with tpm4-tv2 mRNA.
Conclusion: Tpm4-tv1 is a heart-specific isoform of Tpm4 and is essential for heartbeat in zebrafish embryos.
KEYWORDS Zebrafish; Heart; Tropomyosin; Transposon; Thin filament
| 1. Introduction |
|---|
|
|
|---|
The pump function of the heart relies on mechanical properties of myofibrils, each of which consists of thin and thick filaments. Tropomyosin (Tpm) dimers in the form of
-helical coiled-coil wrap around filamentous actin (F-actin) along the thin filament to stabilize the filament.1–3 Tpm is also bound by troponin proteins to form complexes that play an essential role in the regulation of myofilament contractile activation.4 So far, four Tpm genes, Tpm1–4, have been identified in vertebrates. Each Tpm gene can express multiple isoforms by alternative uses of exons and promoters.5 Among these Tpm genes, Tpm1 is the only one that has been found to play an important role in cardiac muscle function and has been shown to associate with familial hypertrophic cardiomyopathy in human.6,7 In contrast, mutations in the TPM2 or TPM3 locus have been found to associate with nemaline myopathy or cap myopathy in skeletal muscle.5,8 In cardiac lethal mutant Mexican axolotl, the embryonic heart has lower levels of Tpm proteins and myosin and fails to beat.9–11 Lack of sarcomeric myofilbrils and heartbeat of this axolotl mutant can be rescued by overexpression of murine
-Tpm/Tpm1 or ATmC-3/Tpm4,12,13 suggesting that lack of either Tpm1 or Tpm4 is responsible for the heartbeat failure. Interestingly, the 5'UTR and the coding regions of Tpm4 cDNA isolated from the mutant axolotl hearts do not carry any mutations,13 which questions the fundamental role of Tpm4 in the heartbeat of the axolotl embryos. Thus, it remains unclear whether Tpm4 is required for the heart development and function. The involvement of Tpm2 and Tpm3 in the heartbeat of vertebrate embryos is unknown. Chemical mutagenesis in zebrafish has allowed clarification of functions of several cardiac filament components.14–18 Recently developed Tol2 transposon technology has been successfully applied to make transgenic lines, and to trap tissue-specific enhancers or developmentally regulated genes in zebrafish.19 The Tol2 transposon-mediated enhancer and gene trap approaches have been successfully used to generate insertional mutants,20,21 opening alternative ways to create developmental mutants in zebrafish.
In this paper, we report a zebrafish mutant with no heartbeat that was generated by Tol2 transposon-mediated insertional mutagenesis. The heartbeat failure in the mutant embryos is due to reduced amounts and disorganization of myofibrillar filaments in ventricular myocytes. We demonstrate that the mutant phenotype is caused by the absence of functional variant 1 of Tpm4, the longer isoform of 284 amino acids, which is specifically expressed in the embryonic heart.
| 2. Methods |
|---|
|
|
|---|
The investigation conformed with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
2.1 Fish and gene trapping
Gene trap vector T2EGE was modified from T2KSAG19 by replacing the original splicing acceptor (second intron of rabbit β-globin gene) and the SV40 poly(A) signal with the splicing acceptor of the first intron and the poly(A) signal of zebrafish ef1
gene, respectively. One-cell embryos from AB strain were injected with 30–50 pg T2EGE DNA and 30–100 pg transposase mRNA. The injected founder (F0) fish were crossed to wild-type fish of AB strain, and their progeny (F1) were observed for GFP expression using Leica M16F microscope. The GFP-positive transgenic embryos, in which GFP expression pattern was presumably identical to that of the trapped gene, were grown up to establish transgenic lines. In this pilot experiment, we established 11 transgenic lines that expressed GFP in various tissues, 2 of which, including T2EGEZ8, gave rise to mutant phenotypes when bred to homozygotes. The genotypes of heterozygous and homozygous fish of this line were indicated by T2EGEZ8+/m and T2EGEZ8m/m, respectively.
Tg(flk1:RFP);T2EGEZ8+/m double transgenic embryos were generated by crossing Tg(flk1:RFP) homozygous fish, which express RFP in vascular vessels, to T2EGEZ8+/m fish. Tg(flk1:RFP);T2EGEZ8m/m were obtained by crossing Tg(flk1:RFP);T2EGEZ8+/m fish.
2.2 TAIL-PCR, RT–PCR, and tpm4 cDNA cloning
To identify genomic sequences flanking integrated transposon, TAIL-PCR was performed essentially as described by Parinov et al.22 Total RNA was extracted from 35 wild-type or transgenic embryos using the Trizon RNA isolation kit (Invitrogen) and used to make the first-strand cDNA by reverse transcription using M-MLV reverse Transcriptase (Promega). Specific primer sets for RT–PCR included V1D5 (5'-GAGAGGCATGAAGGTAATCGAG-3') and V1B3 (5'-AGTAGAGCGAGACAGATGGATC-3') for tpm4-tv1; V2D5 (5'-ATGAAGGACGAGGAGAAGATGGAG-3') and V2D3 (5'-GCATTCCCAGGTTTTCTTCTTTTG-3') for tpm4-tv2; V1D5 and EGFPr3 (5'-GCTGAACTTGTGGCCGTTTAC-3') for tpm4-tv1-GFP fusion transcript; V2D5 and EGFPr3 for tpm4-tv2-GFP fusion transcript; actin5 (5'-ATGGATGATGAAATTGCCGCAC-3') and actin3 (5'-ACCATCACCAGAGTCCATCACG-3') for β-actin. PCR reactions were carried out as follows: denaturation for 3 min at 94°C; 33 cycles (94°C for 45 s; 56°C for 45 s; 72°C for 60 s); final extension for 7 min at 72°C. PCR products were analysed on 2% agarose gel.
The coding sequences of tpm4-tv1 (GenBank accession number NM_001024467), tpm4-stv1 lacking the exon 9 of tpm4-tv1 and tpm4-tv2 (GenBank accession number NM_213158 [GenBank] ) were amplified by RT–PCR using primers V1-B5 (5'-AGATCAACCTGCAACCATGGAG-3') and V1-B3 (5'- AGTAGAGCGAGACAGATGGATC-3') for tpm4-tv1 or V1-B5 and sV1E3 (5'-TTAAATGGAGGTCATGTCGTTG-3') for tpm4-stv1 or V2-B5 (5'- ATGACAGGTGTGACTTCTTTGGAC-3') and V2-3B (5'- ACGTCGTTTTCTCTCATCGTCTTG-3') for tpm4-tv2. The resulted products were cloned into the vector pXT7 for in vitro synthesis of mRNA. Amplification of tpm4-tv1-specific, tpm4-tv2-specific and consensus cDNA sequences used the following primer sets V1S5 (5'-CGGGATCCATTTCTGGCAGCTCCTGGTTGCATG-3') and V1S3 (5'- CCCAAGCTTGTCAGCAGCTTTTTTCTCAGACAG-3'), V2S5 (5'- CGGGATCCAAAATTATCTTCTGCAAAAGAAG-3') and V2S3 (5'- CCCAAGCTTATAAAAATTTATTACACAGAAAGTG-3'), and C5 (5'-AAGCTGCTGACGCGGAGGGTGATG-3') and C3 (5'-GAGTTCATCTTCAAGGTCATCAATG-3'), respectively. These sequences were individually cloned into pXT vector, which lack β-globin-derived untranslated regions, for making in situ hybridization probes.
2.3 Whole-mount in situ hybridization, morpholinos, microinjection and genotyping
Digoxigenin-UTP-labelled antisense RNA probes and capped mRNA were synthesized by in vitro transcription (Roche). The used morpholinos (MO) were V1MO1 (5'-ATCTGGTGTTCTGACGAGAAATT-3'), V1MO2 (5'-TTGAAAGTGTGGTCAGACTAAT-3'), V2MO1 (5'-AGGCTAAAAACTCTATTGTACCCCG-3'), V2MO2 (5'-GTCACACCTGTCATTTTAACTAGCT-3'), and sMO1 (5'-GTAGACGATACCATTCAGCGACTTC-3'). MOs or mRNAs were injected into yolk of embryos at the one-cell stage.
T2EGEZ8+/m and T2EGEZ8m/m embryos were separated from wild-type embryos based on the presence of GFP fluorescence. For separating T2EGEZ8m/m from T2EGEZ8+/m at or before 24 h post-fertilization (hpf), genomic DNA was extracted from single embryos after whole-mount in situ hybridization and photography. Wild-type tpm4-tv1 allele was amplified using primers Tpm4IN5 (5'-ATGCTTCCTTCAGATGACTCAAAC-3') and Tpm4IN3 (5'-GGACTAAACTTTGTGATCTCGTAC-3'). The presence or the absence of a 592 bp fragment identified T2EGEZ8+/m or T2EGEZ8m/m embryos, respectively.
2.4 Transmission electron microscopy
The whole embryos or isolated hearts at 3-day post-fertilization (dpf) and 5 dpf were fixed, embedded in the Spur resin, and sectioned. The sections were stained with uranyl acetate and lead citrate and observed under a transmission electron microscope (JEM-1010).
| 3. Results |
|---|
|
|
|---|
3.1 Expression pattern of the trapped gene in the T2EGEZ8 trapped line
We performed an insertional mutagenesis using a modified Tol2-based transposon trap vector, T2EGE, which contained a promoterless GFP reporter. One of our trapped transgenic lines, T2EGEZ8, showed GFP expression in the heart and other tissues. Because a proportion of T2EGEZ8m/m homozygous embryos exhibited heartbeat failure, we characterized this line in detail.
Observation of 1,454 embryos from 15 pairwise crosses of T2EGEZ8+/m heterozygous fish identified 26.5% of embryos with brighter GFP (homozygous insertion), 49.8% with weaker GFP (heterozygous insertion) and 23.7% without GFP (no insertion), showing an inheritance fashion in accordance with Mendel's law of segregation. When heterozygous fish were mated to wild-type fish, half of their progeny displayed an identical GFP expression pattern and the other half had no GFP, suggesting that a single insertion is directly associated with GFP expression.
GFP expression in T2EGEZ8 embryos becomes detectable in the head and lateral plate mesoderm, the notochord and the neural tube during mid-segmentation (Figure 1A). At 1 dpf, GFP is prominent in various head and trunk vasculature, including metencephalic artery, middle cerebral vein, optic veins, dorsal aorta, cardinal vein, and intersegmental vessels, as well as in somitic boundaries, horizontal myoseptum, and the presumptive floor plate (Figure 1B). At Day 2, GFP expression pattern is not altered (Figure 1C and E–H), but GFP is more clearly seen in branchial arteries (Figure 1E) and in both the atrium and ventricle of the heart (Figure 1F). Around Day 5, hepatic vessels, swim bladder arteries and intestinal vessels are also GFP-positive (Figure 1L–N). In Tg(flk1:RFP);T2EGEZ8 double transgenic embryos, RFP-positive vascular endothelial cells are also GFP-positive (Figure 1I), suggesting the expression of the trapped gene in these cells. In addition, we noted that some circulating blood cells, presumably macrophages, were GFP-positive after 3 days of development (Supplementary material online, Movie S1). These observations suggest that the trapped gene in T2EGEZ8 fish may be primarily involved in the development of the heart and the vasculature.
|
3.2 Failure of the heartbeat in T2EGEZ8 homozygous mutant embryos
In wild-type zebrafish, the embryonic heart beats at 26–28 hpf, resulting in circulation of haematopoietic cells. We found that the heart of T2EGEZ8 homozygous embryos, which were separated from heterozygotes by their higher levels of GFP, never beat visibly (Supplementary material online, Movies S2 andS3, and see Supplementary material online, Figure S1) and died at 7–9 dpf. Homozygous mutants started to display pericardial oedema, an enlarged heart and smaller eyes at 2 dpf (Figure 1D, J and K). The number of blood cells in homozygous mutants appeared to be comparable to that in wild-type or heterozygous siblings (Figure 1D), but they did not visibly flow (Supplementary material online, Movie S4 and see Supplementary material online, Figure S1), suggesting normal haematopoiesis in the mutants. At 5 dpf, 31 of 116 mutants had blood cells in the atrium and another 31 of 116 mutants had these cells in both the atrium and ventricles, indicating that the vasculature might have functioned normally. Considering that the mutants had no heartbeats, we speculated that the flow of blood cells could be driven by mechanical movement of the whole body. This hypothesis was confirmed by the observation that touch-induced movements of 3-day mutant embryos caused immediate rostral flow of blood cells in the posterior caudal vein (data not shown).
The homozygous embryos at 48 hpf moved normally responding to a mechanical touch (Supplementary material online, Movies S5 and S6), implying that the neuronal networks and the muscular system may not been affected. T2EGEZ8 heterozygous embryos survived to adulthood. Taken together, our data suggest that the transposon insertion in T2EGEZ8 fish disrupts a gene essential for early heart function.
3.3 Normal expression of heart-, vasculature-, or musculature-specific markers in T2EGEZ8 mutant embryos
To confirm defects in T2EGEZ8 mutants, we examined the expression of genes that are involved in the development of the heart, vasculature, and musculature. The expression level of the cardiac mesoderm marker nkx2.5, the heart tube marker cmlc2, the atrial marker amhc, and the ventricular marker vmhc was unaltered at various stages in the mutant embryos (Figure 2), suggesting that the specification of the cardiac mesoderm and the formation of the heart chambers are not affected. Similarly, the haemangioblast marker scl1, the haematopoietic stem cell marker gata2, and the vascular endothelial markers fli1a, flk1, and flt4 all exhibited normal expression patterns in mutants (see Supplementary material online, Figure S2), indicating that vasculogenesis, angiogenesis, and haematopoiesis took place normally in these embryos. The erythroid/myeloid progenitor marker gata1 was expressed normally in mutants before circulation started. When the gata1-positive cells in wild-type siblings all had entered the circulation at 36 hpf, however, these cells in the mutants were still present in posterior region of the intermediate cell mass (ICM) (see Supplementary material online, Figure S2C), indicative of a secondary effect of the heartbeat failure. Additionally, we examined the expression of the muscle marker myoD and the somite marker tgfbi, and failed to detect abnormal expression (see Supplementary material online, Figure S3A and B). The organization of actin filaments in fast muscle, slow muscle, and myoseptum, which were detected by phalloidin staining, appeared to be normal in 3-day mutants (see Supplementary material online, Figure S3C and D). Thus, the disruption of the trapped gene in T2EGEZ8 may not interfere with the formation of the skeletal musculature. We hypothesize that loss of Tpm4 function in the developmental processes/tissues discussed here might have been compensated by other members of the Tropomyson family in the mutants.
|
3.4 Interruption of tpm4 gene by the transposon insertion in T2EGEZ8 transgenic line
We then went on to identify the gene trapped in T2EGEZ8 transgenic fish. A total of eight fragments were obtained through TAIL-PCR. Sequencing analysis revealed that five of these fragments were derived from the tpm4 locus, two represented vector integration without transposon excision, and one was a sequence of unknown characteristics. Further sequencing and bioinformatics analyses disclosed that the transposon was integrated into the ninth intron between exons 8 and 9a of the tpm4 locus (Figure 3A). The tpm4 gene is predicted to express two transcript variants, tpm4-tv1 and tpm4-tv2, by using alternative promoter and exons. tpm4-tv1 and tpm4-tv2 share exons 3, 4, 5, 6b, 7, and 8, and encode 284- and 248 amino acids proteins, respectively. The integration of the transposon downstream the common eighth exon was expected to result in production of fusion transcripts tpm4-tv1-GFP (v1G) and tpm4-tv2-GFP (v2G) in T2EGEZ8 transgenic fish (Figure 3B). We confirmed the presence of v1G and v2G transcripts in both T2EGEZ8 homozygotes and heterozygotes by RT–PCR analysis using specific primers (Figure 3C). Importantly, wild-type tpm4-tv1 and tpm4-tv2 were not detected in the homozygotes by RT–PCR; and their amounts in heterozygotes were lower than that in wild-type siblings. This suggests that the transposon insertion completely eliminates the expression of wild-type tpm4 mRNAs, and that their absence is related to the heartbeat failure in T2EGEZ8 mutants.
|
3.5 Distinct expression patterns of two variants of tpm4 during embryogenesis
We examined spatiotemporal expression of tpm4-tv1 and tpm4-tv2 during zebrafish embryogenesis by whole-mount in situ hybridization using variant-specific probes (Figure 4A). tpm4-tv1 transcript became detectable around the 20-somite stage in the presumptive myocardial cells (data not shown). This variant was expressed evenly in the whole heart tube before 40 hpf (Figure 4B–D). Its expression level was higher in the ventricle than in the atrium at 48 hpf (Figure 4E) and became very low at 72 hpf (Figure 4F). Thus, tpm4-tv1 is a heart-specific isoform in zebrafish.
|
The expression pattern of tpm4-tv2 differs from that of tpm4-tv1. tpm4-tv2 transcripts became detectable at the 3-somite stages in the cephalic mesoderm (presumptive rostral blood island) and lateral plate mesoderm (presumptive ICM precursors) (data not shown). At the 10-somite stage, its expression in the head and lateral plate mesoderm was more prominent with appearance of a midline domain (neural tube) (Figure 4G–I). The expression of tpm4-tv2 retained in the head and trunk vessels and dorsal neural tube at 24 hpf (Figure 4J) and 30 hpf (Figure 4K), and it declined below detectable levels after 2 days of development. Thus, tpm4-tv2 appears to be a vasculature-specific isoform. The GFP expression pattern in T2EGEZ8 embryos, as described earlier, resembled a combination of tpm4-tv1 and tpm-v2 expression patterns, supporting a notion that the former results from a fusion of endogenous tpm4-tv1 and tpm4-tv2 to GFP by splicing. Comparing with GFP pattern in T2EGEZ8 embryos, neither of tpm4 transcript variants was detected by in situ hybridization in the floor plate, horizontal myoseptum, and somitic boundaries, which could be ascribed to sensitivity limit of the probes.
We also examined tpm4 expression pattern using a consensus sequence, which was shared by tpm4-tv1 and tpm4-tv2, as a probe. This probe detected strong expression in myotomes in addition to in the heart at various stages (Figure 4L–P), which was identical to that described in ZFIN expression database (http://zfin.org) but different from the GFP pattern in T2EGEZ8 embryos. We speculated that the detected expression in myotomes resulted from cross-hybridization to other Tpm family genes.
We compared the expression level of tpm4-tv1 in the heart by whole-mount in situ hybridization in wild-type, heterozygous, and homozygous embryos (Figure 4Q–V). Prior to or at 24 hpf, no change in tpm4-tv1 expression level was detected (Figure 4Q–S). At 36 hpf, its expression level in the homozygous mutants was higher than wild-type embryos (data not shown). This difference in the ventricle of the heart become more obvious at 48 hpf, with the highest level in mutant, middle level in heterozygote, and the lowest level in wild-type embryos. This suggests that a feedback regulatory mechanism exists for maintaining an appropriate amount of functional Tpm4-tv1 protein.
3.6 Heartbeat failure due to absence of Tpm4-tv1
We next investigated functions of different tpm4 variants during zebrafish embryogenesis by MO knockdown and overexpression approaches. We designed five antisense MO oligonucleotides: two translational MOs targeting tpm4-tv1 (v1MO1 and v1MO2), two translational MOs targeting tpm4-tv2 (v2MO1 and v2MO2), and one splicing MO (sMO1) targeting the junction sequence between the fifth exon and the sixth intron. The targeting efficiency of these MOs was tested in T2EGEZ8 embryos by observing GFP expression following injections. We found that v1MO1 and v1MO2 were unable to block GFP production of transgenic embryos and that injected embryos developed normally with normal heartbeat (data not shown), suggesting ineffectiveness of these two MOs. Injections of v2MO1 and v2MO2 completely inhibited GFP expression in the vasculature but not in the heart and caused no detectable defects (data not shown), suggesting that tpm4-tv2 is dispensable during fish embryogenesis. sMO1 injection abolished GFP expression in the heart and vasculature of T2EGEZ8 embryos (Figure 5A and B), suggesting that it is able to block production of both Tpm4-tv1 and Tpm4-tv2 proteins. Wild-type embryos injected with 20 ng sMO1 manifested no heartbeats and no circulation with a pericardial oedema and smaller eyes, but otherwise normal appearance (Figure 5C and Supplementary material online, Movies S7 and S8). sMO1-induced defects phenocopied those of T2EGEZ8 mutants. Importantly, coinjection with tpm4-tv1 mRNA, but not with tpm4-v2 mRNA or tpm4-stv1 mRNA, which is identical to tpm4-tv1 except for the deletion of exon 9, rescued sMO1-induced defects in wild-type embryos (Figure 5D). Taking these data together, we propose that tpm4-tv1 rather than tpm4-tv2 is essential for the heartbeat of zebrafish embryos. We also noted that overexpression of tpm4-stv1 mRNA or tpm4-tv1-GFP fusion mRNA in wild-type embryos did not affect the heartbeat and blood circulation. This implies that the truncated protein lacking C-terminal of Tpm4-tv1 and Tpm4-tv1-GFP fusion protein may not have a dominant-negative effect on wild-type Tpm4-tv1.
|
3.7 Sarcomeric defects in myocytes of T2EGEZ8 mutant heart
Vertebrate dimeric Tpm molecules form head-to-tail polymers and binds to actin along thin filaments, which are believed to stabilize the filaments.23–25 Tpm proteins also regulate muscle contraction by binding to other components of the contractile apparatus.26 The important role of Tpm in muscle contraction and relaxation and the heart-specific expression of tpm4-tv1 prompted us to examine heart filament structures in the heart of T2EGEZ8 mutant embryos by transmission electron microscopy. As shown in Figure 6, ventricular cardiomyocytes in wild-type embryos at 3 and 5 dpf contained abundant myofibrils with distinct sarcomeric structures such as A-band, I-bands, and Z-discs (Figure 6A, A', C and C'). In contrast, in cardiomyocytes of T2EGEZ8 homozygous mutant embryos the amount of myofibrils was reduced; the arrays of existing sarcomeres were disorganized; and Z-discs of sarcomeres were absent (Figure 6B, B', D and D'). The sarcomeric defects in the T2EGEZ8 mutant heart resemble those found in zebrafish sih/TNNT2 and pik/titin mutants that exhibit loss of cardiac contractility.15,16 The fact that loss of the C-terminal region of Tpm4-tv1 in the mutant embryos affects sarcomere assembly and stability supports the idea that the C-terminal region of Tpm4-tv1 is necessary for forming the head-to-tail array of Tpm molecules.
|
| 4. Discussion |
|---|
|
|
|---|
In summary, we generated a zebrafish mutant with heartbeat failure, T2EGEZ8 mutant, using Tol2 transposon-mediated mutagenesis. The heartbeat failure of T2EGEZ8 mutant embryos was due to instability of cardiac filaments. We further demonstrated that the 284-amino acids variant of tpm4 gene was specifically expressed in the heart and its loss caused embryonic heartbeat failure in zebrafish.
Structural studies mainly on skeletal muscle Tpm indicate that
-Tpm dimers form long linear polymers in a head-to-tail fashion and the polymers wind around and protect the actin filaments.1,2,25 The head-to-tail linear aggregation of parallel-aligned Tpm dimers absolutely requires their nine N-terminal and nine C-terminal residues.27,28 The longer form of Tpm4 should have the same structural characteristics. In T2EGEZ8 mutant embryo, the insertion of the transposon genome into the tpm4 locus led to production of Tpm4-tv1-GFP and Tpm4-tv2-GFP fusion proteins (Figure 3). In Tpm4-tv1-GFP, N-terminal 257-amino acids region of Tpm4-tv1 was fused to GFP, resulting in loss of C-terminal 27 residues of Tpm4-tv1. We postulate that the absence of C-terminal 27 residues of Tpm4-tv1 in the mutants could lead to loss of the ability of head-to-tail intermolecular aggregation of Tpm4-tv1-GFP in the mutant myocytes, and as a result the filamentous actin fibres become instable. It will be interesting to test if Tpm4-tv1-GFP is indeed unable to form head-to-tail aggregates.
The tpm4 gene in zebrafish expresses two variants, 284-amino acid Tpm4-tv1 and 248-amino acid Tpm4-tv2. As shown above, the tpm4-tv1 is a heart-specific variant and plays an essential role in cardiac contractility. The Tpm4 locus has also been found to express two isoforms, 284- and 248-amino acid proteins, in chick,29 frog,30 and pufferfish.31 In these species, the 284-amino acid Tpm4 is predominantly expressed in the heart, whereas the 248-amino acid isoform is expressed in more types of tissues. We would expect that Tpm4 also play an important role in cardiac muscle contraction and relaxation in these species. By exploring NCBI databases, we found at least two human cDNA clones (with GenBank accession numbers CR599958 [GenBank] and AK023385 [GenBank] ) that encode the 284-amino acid isoform of TPM4, and noted that TPM4 ESTs are present in the human heart tissue. It is likely that the human TPM4 is also a component of cardiac contractile apparatus and that its mutations may cause heart diseases. tpma, another Tpm family gene in zebrafish, has been reported to express in the heart of zebrafish embryos, and its expression is significantly reduced in troponin T mutant.15 The expression of tpma in T2EGEZ8 mutant embryos appeared to be slightly reduced at 24 hpf (see Supplementary material online, Figure S4), suggesting that tpma expression requires Tpm4-tv1 function. Unlike tpm4-tv1, however, tpma expression was not detected in wild-type or T2EGEZ8 mutant embryos at 36 hpf, implying that they might have distinct activities at different developmental stages.
Tpm4-tv2 is expressed in the vasculature and the dorsal neural tube. However, its interruption in T2EGEZ8 homozygous embryos or its MO knockdown in wild-type embryos fails to cause detectable abnormalities in the vasculature and motility, suggesting that other Tpm proteins can compensate for loss of Tpm4-tv2. The potential candidates in zebrafish that may have redundant functions with tpm4-tv2 include tpm3 and tpm4-like, which have an expression pattern similar to tpm4-tv2 (http://zfin.org).
| Supplementary material |
|---|
|
|
|---|
Supplementary material is available at Cardiovascular Research online.
| Funding |
|---|
|
|
|---|
This work was supported by grants from the 863 Program (#2006AA02Z167), from the Major Science Programs of China (#2006CB943401), and from the National Basic Research Program of China (#2005CB522502).
| Acknowledgements |
|---|
We are grateful to Dr K. Kawakami for providing Tol2 reagents, Dr S. Lin for Tg(flk1:RFP) fish, and Dr Ning Yan for helpful discussion. We thank other members of Meng Lab for helps and discussions.
Conflict of interest: none declared.
| Notes |
|---|
These authors contributed equally to this work. | References |
|---|
|
|
|---|
- McLachlan AD, Stewart M. Tropomyosin coiled-coil interactions: evidence for an unstaggered structure. J Mol Biol (1975) 98:293–304.[CrossRef][Web of Science][Medline]
- Phillips GN Jr, Lattman EE, Cummins P, Lee KY, Cohen C. Crystal structure and molecular interactions of tropomyosin. Nature (1979) 278:413–417.[CrossRef][Web of Science][Medline]
- Li Y, Mui S, Brown JH, Strand J, Reshetnikova L, Tobacman LS, et al. The crystal structure of the C-terminal fragment of striated-muscle alpha-tropomyosin reveals a key troponin T recognition site. Proc Natl Acad Sci USA (2002) 99:7378–7383.
[Abstract/Free Full Text] - Gordon AM, Regnier M, Homsher E. Skeletal and cardiac muscle contractile activation: tropomyosin rocks and rolls. News Physiol Sci (2001) 16:49–55.
[Abstract/Free Full Text] - Perry SV. Vertebrate tropomyosin: distribution, properties and function. J Muscle Res Cell Motil (2001) 22:5–49.[CrossRef][Web of Science][Medline]
- Tardiff JC. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev (2005) 10:237–248.[CrossRef][Web of Science][Medline]
- Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol (2008) 19:104–110.[Web of Science][Medline]
- Laing NG. Congenital myopathies. Curr Opin Neurol (2007) 20:583–589.[Web of Science][Medline]
- Lemanski LF. Morphology of developing heart in cardiac lethal mutant Mexican axolotls, Ambystoma mexicanum. Dev Biol (1973) 33:312–333.[CrossRef][Web of Science][Medline]
- Moore PB, Lemanski LF. Quantification of tropomyosin by radioimmunoassay in developing hearts of cardiac mutant axolotls, Ambystoma mexicanum. J Muscle Res Cell Motil (1982) 3:161–167.[CrossRef][Web of Science][Medline]
- Starr CM, Diaz JG, Lemanski LF. Analysis of actin and tropomyosin in hearts of cardiac mutant axolotls by two-dimensional gel electrophoresis, western blots, and immunofluorescent microscopy. J Morphol (1989) 201:1–10.[CrossRef][Web of Science][Medline]
- Zajdel RW, McLean MD, Lemanski SL, Muthuchamy M, Wieczorek DF, Lemanski LF, et al. Ectopic expression of tropomyosin promotes myofibrillogenesis in mutant axolotl hearts. Dev Dyn (1998) 213:412–420.[CrossRef][Web of Science][Medline]
- Spinner BJ, Zajdel RW, McLean MD, Denz CR, Dube S, Mehta S, et al. Characterization of a TM-4 type tropomyosin that is essential for myofibrillogenesis and contractile activity in embryonic hearts of the Mexican axolotl. J Cell Biochem (2002) 85:747–761.[CrossRef][Web of Science][Medline]
- Berdougo E, Coleman H, Lee DH, Stainier DY, Yelon D. Mutation of weak atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular morphogenesis in zebrafish. Development (2003) 130:6121–6129.
[Abstract/Free Full Text] - Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet (2002) 31:106–110.[CrossRef][Web of Science][Medline]
- Xu X, Meiler SE, Zhong TP, Mohideen M, Crossley DA, Burggren WW, et al. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nat Genet (2002) 30:205–209.[Web of Science][Medline]
- Rottbauer W, Wessels G, Dahme T, Just S, Trano N, Hassel D, et al. Cardiac myosin light chain-2: a novel essential component of thick-myofilament assembly and contractility of the heart. Circ Res (2006) 99:323–331.
[Abstract/Free Full Text] - Hinits Y, Hughes SM. Mef2s are required for thick filament formation in nascent muscle fibres. Development (2007) 134:2511–2519.
[Abstract/Free Full Text] - Kawakami K, Takeda H, Kawakami N, Kobayashi M, Matsuda N, Mishina M. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Dev Cell (2004) 7:133–144.[CrossRef][Web of Science][Medline]
- Nagayoshi S, Hayashi E, Abe G, Osato N, Asakawa K, Urasaki A, et al. Insertional mutagenesis by the Tol2 transposon-mediated enhancer trap approach generated mutations in two developmental genes: tcf7 synembryn-like. Development (2008) 135:159–169.
[Abstract/Free Full Text] - Kotani T, Kawakami K. Misty somites, a maternal effect gene identified by transposon-mediated insertional mutagenesis in zebrafish that is essential for the somite boundary maintenance. Dev Biol (2008) 316:383–396.[CrossRef][Web of Science][Medline]
- Parinov S, Kondrichin I, Korzh V, Emelyanov A. Tol2 transposon-mediated enhancer trap to identify developmentally regulated zebrafish genes in vivo. Dev Dyn (2004) 231:449–459.[CrossRef][Web of Science][Medline]
- Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol (1996) 58:447–481.[CrossRef][Web of Science][Medline]
- Brown JH, Kim KH, Jun G, Greenfield NJ, Dominguez R, Volkmann N, et al. Deciphering the design of the tropomyosin molecule. Proc Natl Acad Sci USA (2001) 98:8496–8501.
[Abstract/Free Full Text] - Whitby FG, Phillips GN Jr. Crystal structure of tropomyosin at 7 Angstroms resolution. Proteins (2000) 38:49–59.[CrossRef][Web of Science][Medline]
- Wolska BM, Wieczorek DM. The role of tropomyosin in the regulation of myocardial contraction and relaxation. Pflugers Arch (2003) 446:1–8.[CrossRef][Web of Science][Medline]
- Sano K, Maeda K, Oda T, Maeda Y. The effect of single residue substitutions of serine-283 on the strength of head-to-tail interaction and actin binding properties of rabbit skeletal muscle alpha-tropomyosin. J Biochem (Tokyo) (2000) 127:1095–1102.
[Abstract/Free Full Text] - Greenfield NJ, Huang YJ, Swapna GV, Bhattacharya A, Rapp B, Singh A, et al. Solution NMR structure of the junction between tropomyosin molecules: implications for actin binding regulation. J Mol Biol (2006) 364:80–96.[CrossRef][Web of Science][Medline]
- Forry-Schaudies S, Gruber CE, Hughes SH. Chicken cardiac tropomyosin and a low-molecular-weight nonmuscle tropomyosin are related by alternative splicing. Cell Growth Differ (1990) 1:473–481.[Abstract]
- Hardy S, Theze N, Lepetit D, Allo MR, Thiebaud P. The Xenopus laevis TM-4 gene encodes non-muscle and cardiac tropomyosin isoforms through alternative splicing. Gene (1995) 156:265–270.[CrossRef][Web of Science][Medline]
- Toramoto T, Ikeda D, Ochiai Y, Minoshima S, Shimizu N, Watabe S. Multiple gene organization of pufferfish Fugu rubripes tropomyosin isoforms and tissue distribution of their transcripts. Gene (2004) 331:41–51.[CrossRef][Web of Science][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





